Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 59

    1.

    Animal rabies in Massachusetts, 1985-2006.

    Wang X, Werner BG, Konomi R, Hennigan D, Fadden D, Caten E, Soliva S, DeMaria A.

    J Wildl Dis. 2009 Apr;45(2):375-87.PMID: 19395747 [PubMed - indexed for MEDLINE]Related articles

    2.

    Human eastern equine encephalitis in Massachusetts: predictive indicators from mosquitoes collected at 10 long-term trap sites, 1979-2004.

    Hachiya M, Osborne M, Stinson C, Werner BG.

    Am J Trop Med Hyg. 2007 Feb;76(2):285-92.PMID: 17297037 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Committee on microbiology and extraneous materials.

    Agin JR, Ziemer WA, Newman MC, Guilfoyle DE, Vought K, Ledenbach L, Brodsky MH, Hill W, Rice D, Ferreira JL, Werner BG, Martin BM, Shively R, Marrow T, Phillips RW, Wehling P, Labudde RA; AOAC. Committee on microbiology and extraneous materials.

    J AOAC Int. 2006 Nov-Dec;89(6):1700-1. No abstract available. PMID: 17225618 [PubMed - indexed for MEDLINE]Related articles

    4.

    Implementing a routine, voluntary HIV testing program in a Massachusetts county prison.

    Liddicoat RV, Zheng H, Internicola J, Werner BG, Kazianis A, Golan Y, Rubinstein EP, Freedberg KA, Walensky RP.

    J Urban Health. 2006 Nov;83(6):1127-31.PMID: 16897416 [PubMed - indexed for MEDLINE]Related articles

    5.

    Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.

    Choe LH, Werner BG, Lee KH.

    NeuroRx. 2006 Jul;3(3):327-35. Review.PMID: 16815216 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes.

    Doron S, Ruthazer R, Werner BG, Rabson A, Snydman DR.

    Transplantation. 2006 Mar 15;81(5):697-703.PMID: 16534471 [PubMed - indexed for MEDLINE]Related articles

    8.

    Low pressure CO2 storage of raw milk: microbiological effects.

    Rajagopal M, Werner BG, Hotchkiss JH.

    J Dairy Sci. 2005 Sep;88(9):3130-8.PMID: 16107402 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    New method for detection of Mycobacterium tuberculosis Direct Test inhibitors in clinical specimens.

    Sloutsky A, Han LL, Werner BG.

    Diagn Microbiol Infect Dis. 2004 Oct;50(2):109-11.PMID: 15474319 [PubMed - indexed for MEDLINE]Related articles

    10.

    Practical strategies for performance optimization of the enhanced gen-probe amplified mycobacterium tuberculosis direct test.

    Sloutsky A, Han LL, Werner BG.

    J Clin Microbiol. 2004 Apr;42(4):1547-51.PMID: 15071002 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection.

    Hanna GJ, Balaguera HU, Freedberg KA, Werner BG, Steger Craven KA, Craven DE, D'Aquila RT.

    J Infect Dis. 2003 Oct 1;188(7):986-91. Epub 2003 Sep 10.PMID: 14513418 [PubMed - indexed for MEDLINE]Related articles

    12.

    Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection.

    Doron SI, Dashe JF, Adelman LS, Brown WF, Werner BG, Hadley S.

    Clin Infect Dis. 2003 Sep 1;37(5):e74-7. Epub 2003 Aug 11.PMID: 12942423 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of carbon dioxide on bacterial growth parameters in milk as measured by conductivity.

    Martin JD, Werner BG, Hotchkiss JH.

    J Dairy Sci. 2003 Jun;86(6):1932-40.PMID: 12836927 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of carbon dioxide on the growth of Bacillus cereus spores in milk during storage.

    Werner BG, Hotchkiss JH.

    J Dairy Sci. 2002 Jan;85(1):15-8.PMID: 11860107 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.

    DesJardin JA, Cho E, Supran S, Gibbons L, Werner BG, Snydman DR.

    Clin Infect Dis. 2001 Oct 15;33(8):1358-62. Epub 2001 Sep 20.PMID: 11565077 [PubMed - indexed for MEDLINE]Related articles

    16.

    Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study.

    Snydman DR, Falagas ME, Avery R, Perlino C, Ruthazer R, Freeman R, Rohrer R, Fairchild R, O'Rourke E, Hibberd P, Werner BG.

    Transplant Proc. 2001 Jun;33(4):2571-5. No abstract available. PMID: 11406251 [PubMed - indexed for MEDLINE]Related articles

    17.

    Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection.

    DesJardin JA, Gibbons L, Cho E, Supran SE, Falagas ME, Werner BG, Snydman DR.

    J Infect Dis. 1998 Dec;178(6):1783-6.PMID: 9815234 [PubMed - indexed for MEDLINE]Related articles

    18.

    Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

    Falagas ME, Paya C, Ruthazer R, Badley A, Patel R, Wiesner R, Griffith J, Freeman R, Rohrer R, Werner BG, Snydman DR.

    Transplantation. 1998 Oct 27;66(8):1020-8.PMID: 9808486 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.

    Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, Freeman R, Rohrer R.

    Clin Transplant. 1997 Oct;11(5 Pt 1):432-7.PMID: 9361936 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

    Falagas ME, Snydman DR, Griffith J, Werner BG, Freeman R, Rohrer R.

    Clin Infect Dis. 1997 Aug;25(2):314-7.PMID: 9332531 [PubMed - indexed for MEDLINE]Related articles

    22.

    Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients.

    Falagas ME, Arbo M, Ruthazer R, Griffith JL, Werner BG, Rohrer R, Freeman R, Lewis WD, Snydman DR.

    Transplantation. 1997 Jun 15;63(11):1595-601.PMID: 9197352 [PubMed - indexed for MEDLINE]Related articles

    24.

    Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group.

    Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG.

    Ann Intern Med. 1997 Feb 15;126(4):275-9.PMID: 9036799 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates.

    Snydman DR, Werner BG, Meissner HC, Cheeseman SH, Schwab J, Bednarek F, Kennedy JL Jr, Herschel M, Magno A, Levin MJ, et al.

    Pediatr Infect Dis J. 1995 Jan;14(1):34-40.PMID: 7715987 [PubMed - indexed for MEDLINE]Related articles

    28.

    A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.

    Snydman DR, Werner BG, Dougherty NN, Griffith J, Rohrer RH, Freeman R, Jenkins R, Lewis WD, O'Rourke E.

    Transplant Proc. 1994 Oct;26(5 Suppl 1):23-7. No abstract available. PMID: 7940972 [PubMed - indexed for MEDLINE]Related articles

    29.

    Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.

    Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, Hammer S, O'Rourke E, Grady GF, Fawaz K, Kaplan MM, Hoffman MA, Katz AT, Doran M; Boston Center for Liver Transplantation CMVIG Study Group.

    Ann Intern Med. 1993 Nov 15;119(10):984-91.PMID: 8214995 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.

    George MJ, Snydman DR, Werner BG, Dougherty NN, Griffith J, Rohrer RH, Freeman R, Jenkins R, Lewis WD.

    Transplant Proc. 1993 Oct;25(5 Suppl 4):22-4. No abstract available. PMID: 8212303 [PubMed - indexed for MEDLINE]Related articles

    31.

    Interference of immune globulin with measles and rubella immunization.

    Siber GR, Werner BG, Halsey NA, Reid R, Almeido-Hill J, Garrett SC, Thompson C, Santosham M.

    J Pediatr. 1993 Feb;122(2):204-11.PMID: 8429432 [PubMed - indexed for MEDLINE]Related articles

    32.

    Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.

    Werner BG, Snydman DR, Freeman R, Rohrer R, Tilney NL, Kirkman RL.

    Transplant Proc. 1993 Feb;25(1 Pt 2):1441-3. No abstract available. PMID: 8382875 [PubMed - indexed for MEDLINE]Related articles

    33.

    New developments in cytomegalovirus prevention and management.

    Snydman DR, Rubin RH, Werner BG.

    Am J Kidney Dis. 1993 Feb;21(2):217-28. Review.PMID: 8381578 [PubMed - indexed for MEDLINE]Related articles

    34.

    Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: implications for public health and obstetric practice.

    Donegan SP, Steger KA, Recla L, Hoff RS, Werner BG, Rice PA, Craven DE.

    Am J Obstet Gynecol. 1992 Sep;167(3):622-9.PMID: 1530014 [PubMed - indexed for MEDLINE]Related articles

    35.

    Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis.

    Tsevat J, Snydman DR, Pauker SG, Durand-Zaleski I, Werner BG, Levey AS.

    Transplantation. 1991 Aug;52(2):259-65.PMID: 1651575 [PubMed - indexed for MEDLINE]Related articles

    36.

    Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.

    Snydman DR, Werner BG, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS, Strom TB, Carpenter CB, et al.

    Transplant Proc. 1991 Feb;23(1 Pt 2):1357-60. No abstract available. PMID: 1846464 [PubMed - indexed for MEDLINE]Related articles

    37.

    Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction.

    Barry MA, Gleavy D, Herd K, Schwingl PJ, Werner BG.

    Am J Public Health. 1990 Apr;80(4):471-3.PMID: 2316772 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial.

    Snydman DR, Werner BG, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS, Strom TB, Carpenter CB, et al.

    Transplant Proc. 1988 Dec;20(6 Suppl 8):24-30. No abstract available. PMID: 2849222 [PubMed - indexed for MEDLINE]Related articles

    39.

    Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.

    Hecht DW, Snydman DR, Crumpacker CS, Werner BG, Heinze-Lacey B.

    J Infect Dis. 1988 Jan;157(1):187-90. No abstract available. PMID: 2826608 [PubMed - indexed for MEDLINE]Related articles

    40.

    Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.

    Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS, et al.

    N Engl J Med. 1987 Oct 22;317(17):1049-54.PMID: 2821397 [PubMed - indexed for MEDLINE]Related articles

    41.

    A crystalline lipid phase in a dry biological system: evidence from X-ray diffraction analysis of Typha latifolia pollen.

    Caffrey M, Werner BG, Priestley DA.

    Biochim Biophys Acta. 1987 Sep 4;921(1):124-34.PMID: 3620484 [PubMed - indexed for MEDLINE]Related articles

    42.

    Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine.

    Kunches LM, Craven DE, Werner BG.

    Am J Med. 1986 Oct;81(4):591-5.PMID: 3766588 [PubMed - indexed for MEDLINE]Related articles

    43.

    Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.

    Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG, Polk BF, Syndman DR, Platt R, Crumpacker CS, et al.

    Ann Intern Med. 1986 Sep;105(3):356-60. Erratum in: Ann Intern Med 1987 Jan;106(1):174. PMID: 2943202 [PubMed - indexed for MEDLINE]Related articles

    44.

    Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination.

    Dienstag JL, Werner BG, McLane MF, Snydman DR, Grady GF, Craven DE, Crumpacker CS, Polk BF, Platt R, Allan J, et al.

    JAMA. 1985 Aug 23-30;254(8):1064-6.PMID: 2991619 [PubMed - indexed for MEDLINE]Related articles

    45.

    Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination.

    Werner BG, Dienstag JL, Kuter BJ, Polk BF, Snydman DR, Craven DE, Crumpacker CS, Platt R, Grady GF.

    Ann Intern Med. 1985 Aug;103(2):201-5.PMID: 3160274 [PubMed - indexed for MEDLINE]Related articles

    46.

    Epidemiology and clinical impact of hepatitis D virus (delta) infection.

    Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK.

    Hepatology. 1985 Mar-Apr;5(2):188-91.PMID: 3979950 [PubMed - indexed for MEDLINE]Related articles

    47.

    A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination.

    Snydman DR, Muñoz A, Werner BG, Polk BF, Craven DE, Platt R, Crumpacker C, Ouellet-Hellstrom R, Nash B, Grady GF, et al.

    Am J Epidemiol. 1984 Nov;120(5):684-93.PMID: 6496449 [PubMed - indexed for MEDLINE]Related articles

    48.

    A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients.

    Snydman DR, McIver J, Leszczynski J, Cho SI, Werner BG, Berardi VP, LoGerfo F, Heinze-Lacey B, Grady GF.

    Transplantation. 1984 Nov;38(5):553-7. No abstract available. PMID: 6093299 [PubMed - indexed for MEDLINE]Related articles

    49.

    Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.

    Dienstag JL, Werner BG, Polk BF, Snydman DR, Craven DE, Platt R, Crumpacker CS, Ouellet-Hellstrom R, Grady GF.

    Ann Intern Med. 1984 Jul;101(1):34-40.PMID: 6233921 [PubMed - indexed for MEDLINE]Related articles

    50.

    Hepatitis B exposure in emergency medical personnel. Prevalence of serologic markers and need for immunization.

    Kunches LM, Craven DE, Werner BG, Jacobs LM.

    Am J Med. 1983 Aug;75(2):269-72.PMID: 6881178 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...